CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 283,637	$ 316,827
Marketable securities, at fair value	182,316	198,563
Accounts receivable, net	111,276	112,130
Inventories	21,863	23,395
Prepaid assets	16,662	12,354
Assets held for sale	0	10,050
Other current assets	6,506	8,189
Total current assets	622,260	681,508
Property and equipment (net of accumulated depreciation of $123,159 and $109,952, respectively)	111,105	109,465
Operating lease right-of-use assets	99,917	102,197
Intangible assets, net	425,338	442,325
Goodwill	527,115	527,115
Other assets	6,378	7,168
Total non-current assets	1,169,853	1,188,270
Total assets	1,792,113	1,869,778
Current liabilities
Accounts payable	16,849	17,921
Accrued compensation	37,280	38,304
Accrued expenses and other liabilities	16,075	17,796
Current portion of equipment financing obligations	410	1,135
Current portion of operating lease liabilities	5,708	6,884
Pharma contract liabilities	6,348	5,192
Total current liabilities	82,670	87,232
Long-term liabilities
Convertible senior notes, net	533,898	532,483
Operating lease liabilities	71,882	72,289
Deferred income tax liabilities, net	45,979	55,475
Other long-term liabilities	14,165	14,022
Total long-term liabilities	665,924	674,269
Commitments and contingencies (Note 11)
Total liabilities	748,594	761,501
Stockholders’ equity
Common stock, $0.001 par value, (250,000,000 shares authorized; 125,679,573 and 124,107,500 shares issued and outstanding, respectively)	126	124
Additional paid-in capital	1,146,997	1,123,628
Accumulated other comprehensive loss	(4,056)	(638)
Accumulated deficit	(99,548)	(14,837)
Total stockholders’ equity	1,043,519	1,108,277
Total liabilities and stockholders’ equity	$ 1,792,113	$ 1,869,778